AVH 0.33% $3.01 avita medical inc.

Enterprise Value, page-342

  1. 371 Posts.
    lightbulb Created with Sketch. 133
    not sure what difference does it make to call it a “cosmetic treatment”? - it is a cosmetic condition… no need to treat it if you are happy to live with white patches on ur skin

    people who have a stable vitiligo are eligible for the recell (refer to inclusion criteria of the trial) - recently approved treatment that u mentioned actually stabilises the condition therefore increases addressable market for recell - btw this was discussed in the recent q2 investor call as well ( have a look at the transcript posted in here)

    repigmentation with recell is far more superior than with cream …


 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.